Search results for "MUCOSA"

showing 10 items of 1066 documents

Massive gastrointestinale Blutung eines 28-jährigen Patienten mit intestinalem Befall eines Morbus Behçet

2006

A 28-year-old man was admitted to the emergency room of our hospital after syncope and acute gastrointestinal bleeding. On the basis of numerous oral and genital ulcerations as well as uveitis anterior and erythema nodosum, the diagnosis of Behcet's disease had been confirmed previously. The bleeding focus could not be detected by endoscopy. During the next days recurrent massive hemorrhages occurred in spite of immunosuppressive therapy with steroids. Angiography revealed a circumscribed bleeding source in the colon transversum near the left colonic flexure, which was treated by superselective coil embolization. A massive hemorrhage reoccurred and required a surgical approach with a Hartma…

Erythema nodosummedicine.medical_specialtymedicine.diagnostic_testbusiness.industryGastroenterologyBehcet's diseasemedicine.diseaseSurgeryEndoscopyIntestinal Hemorrhagemedicine.anatomical_structureSubmucosaAngiographymedicineDifferential diagnosisbusinessUveitisZeitschrift für Gastroenterologie
researchProduct

Polymeric microcontainers improve oral bioavailability of furosemide.

2016

Microcontainers with an inner diameter of 223 μm are fabricated using the polymer SU-8, and evaluated in vitro, in situ and in vivo for their application as an advanced oral drug delivery system for the poorly water soluble drug furosemide. An amorphous sodium salt of furosemide (ASSF) is filled into the microcontainers followed by applying a lid using Eudragit L100. It is possible to control the drug release in vitro, and in vitro absorption studies show that the microcontainers are not a hindrance for absorption of ASSF. In situ perfusion studies in rats are performed with ASSF-filled microcontainers coated with Eudragit and compared to a furosemide solution. The absorption rate constant …

Eudragit l100PolymersPharmaceutical ScienceAdministration OralBiological Availability02 engineering and technologyAbsorption (skin)PharmacologyMicro devices030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineDrug Delivery SystemsPolymethacrylic AcidsIn vivoDelivery systemsFurosemideOral bioavailabilitymedicineAnimalsHumansIntestinal MucosaRats WistarIntestinal mucusChromatographyChemistryFurosemide021001 nanoscience & nanotechnologyBioavailabilityDrug LiberationMucusOral deliveryEpoxy CompoundsFemaleDelivery systemIntestinal perfusionCaco-2 Cells0210 nano-technologyOral retinoidmedicine.drugInternational journal of pharmaceutics
researchProduct

Oral manifestations of gastrointestinal disorders

2017

Indexación: Scopus. Backgroud: A considerable number of gastrointestinal disorders (GIDs) of varied nature (inflammatory, infectious, genetic and other etiology) may produce alterations in the hard and soft oral tissues. Among these are Crohn's disease, ulcerative colitis, celiac and gastroesophageal reflux disease. Material and Methods: Article search was done using the National library of medicine (PubMed) database using different search terms and analyzed according to their importance. Results: A large variety of GIDs can give rise to oral lesions, including: RAS like ulceration, mucosal tags, cobblestoning, mucogingivitis, labial and facial swelling, pyostomatitis vegetans, disgeusia an…

Facial swellingmedicine.medical_specialtyOral lesionsSigns and symptomsReviewDiseaseGastrointestinal disorders03 medical and health sciences0302 clinical medicineQuality of lifeOral mucosal disordersmedicineGeneral DentistryOral Medicine and Pathologybusiness.industry030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ulcerative colitisDermatologystomatognathic diseasesSearch termsUNESCO::CIENCIAS MÉDICASEtiology030211 gastroenterology & hepatologymedicine.symptombusinessPyostomatitis vegetans
researchProduct

Effects of the benzodiazepine receptor agonist midazolam and antagonist flumazenil on 5-hydroxytryptamine release from guinea-pig intestine in vitro

1990

Isolated segments of the guinea-pig small intestine and the guinea-pig stomach were vascularly perfused and the release of 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid into the portal venous effluent determined by high pressure liquid chromatography with electrochemical detection. Test substances were applied intraarterially. The benzodiazepine receptor agonist, midazolam, concentration-dependently increased (by 58%, at 1 nmol/l) and decreased (by 32%, at 100 nmol/l) the release of 5-HT from small intestine preparations. Both effects were blocked by the benzodiazepine receptor antagonist flumazenil (10 nmol/l) The stimulatory effect of midazolam was also abolished in the presen…

FlumazenilMaleAgonistSerotoninmedicine.medical_specialtymedicine.drug_classMidazolamGuinea PigsTetrodotoxinIn Vitro TechniquesBiologychemistry.chemical_compoundInternal medicineIntestine SmallElectrochemistrymedicineAnimalsChromatography High Pressure LiquidPharmacologyBenzodiazepineGABAA receptorStomachAntagonistGeneral MedicineHydroxyindoleacetic AcidBicucullineReceptors GABA-ASmall intestinePerfusionEndocrinologymedicine.anatomical_structurechemistryGastric MucosaFlumazenilChromaffin SystemTetrodotoxinFemalemedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters.

2003

Psoriasis is a chronic inflammatory skin disease. Its treatment is based on the inhibition of proliferation of epidermal cells and interference in the inflammatory process. A new systemic antipsoriasis drug, which consists of dimethylfumarate and ethylhydrogenfumarate in the form of their calcium, magnesium and zinc salts has been introduced in Europe with successful results. In the present study, a homologous series of mono- and diesters of fumaric acid has been studied with respect to the sites and kinetics of presystemic ester degradation using pancreas extract, intestinal perfusate, intestinal homogenate and liver S9 fraction. In addition, intestinal permeability has been determined usi…

Fumaric acidCell Membrane PermeabilitySwineDimethyl FumaratePharmaceutical ScienceBiological AvailabilityPancreatic ExtractsIntestinal absorptionchemistry.chemical_compoundIntestinal mucosaFumaratesmedicineAnimalsHumansPsoriasisPharmacology (medical)Enzyme InhibitorsIntestinal MucosaCells CulturedPharmacologyIntestinal permeabilityDimethyl fumarateMicrovilliGeneral MedicineMetabolismmedicine.diseasePropranololIntestineschemistryBiochemistryS9 fractionAtenololIntestinal AbsorptionLipophilicityCaco-2 CellsLiver ExtractsBiopharmaceuticsdrug disposition
researchProduct

Occurrence, mitigation and in vitro cytotoxicity of nivalenol, a type B trichothecene mycotoxin - Updates from the last decade (2010-2020).

2021

Abstract The present review aims to give an overview of the literature of the last decade (2010–2020) concerning the occurrence of the type B trichothecene mycotoxin nivalenol (NIV) and its in vitro toxicity, with the purpose of updating information regarding last researches on this mycotoxin. The most recent studies on the possible methods for preventing Fusarium spp. growth and NIV production are also discussed. Recently, various environmental factors have been shown to influence strongly NIV occurrence. However, Fusarium spp. of the NIV genotype have been found almost worldwide. With regard to NIV cytotoxicity, NIV has been reported to cause a marked decrease in cell proliferation in dif…

FusariumIn vitro cytotoxicityTrichotheceneFood ContaminationBiologyToxicologymedicine.disease_causechemistry.chemical_compoundFusariumCell Line TumorToxicity TestsmedicineEffective treatmentAnimalsHumansImmunologic FactorsIntestinal MucosaMycotoxinCarcinogenGeneral MedicineMycotoxinsbiology.organism_classificationchemistryImmunologyToxicityTrichothecenesGenotoxicityFood ScienceMutagensFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association
researchProduct

Beauvericin-induced cytotoxicity via ROS production and mitochondrial damage in Caco-2 cells.

2013

The cytotoxicity of beauvericin (BEA) on human colon adenocarcinoma (Caco-2) cells was studied as a function of time. Moreover, the oxidative damage and cell death endpoints were monitored after 24, 48 and 72 h. After BEA exposure, the IC₅₀ values ranged from 1.9 ± 0.7 to 20.6 ± 6.9 μM. A decrease in reduced glutathione (GSH; 31%) levels, as well as an increase in oxidized glutathione (GSSG, 20%) was observed. In the presence of BEA, reactive oxygen species (ROS) level was highly increased at an early stage with the highest production of 2.0-fold higher than the control that was observed at 120 min. BEA induced cell death by mitochondria-dependent apoptotic process with loss of the mitochon…

G2 PhaseProgrammed cell deathDNA damageCell SurvivalApoptosisBiologyToxicologymedicine.disease_causechemistry.chemical_compoundInhibitory Concentration 50NecrosisDepsipeptidesmedicineHumansIntestinal Mucosachemistry.chemical_classificationMembrane Potential MitochondrialReactive oxygen speciesIonophoresCell growthGeneral MedicineGlutathioneMycotoxinsMolecular biologyGlutathioneBeauvericinCell biologyMitochondriaKineticsOxidative StresschemistryApoptosisLipid PeroxidationCaco-2 CellsReactive Oxygen SpeciesOxidation-ReductionOxidative stressDNA DamageToxicology letters
researchProduct

Value of gastrin-17 in detecting antral atrophy.

2011

Decreased plasma gastrin-17 (G-17), particularly after protein stimulation, is indicative of atrophy in the antral stomach mucosa. Available data on the value of this biomarker is inconclusive. Our study was aimed to evaluate the performance of the G-17 test in Caucasian and Asian patients for antral atrophy evaluation either in fasting state or after protein stimulation.241 dyspeptic patients aged 55 and above from Latvia (125), Lithuania (76) and Taiwan (40) were enrolled. G-17 levels were detected in plasma samples obtained either during fasting or after a protein-rich test meal. Levels1 pmol/L at fast and5 pmol/L after stimulation were considered indicative of atrophy.The sensitivity of…

Gastritis AtrophicMalemedicine.medical_specialtyAtrophic gastritisStimulationGastroenterologySensitivity and SpecificityAtrophyPredictive Value of TestsInternal medicineGastrinsmedicineBiomarkers TumorHumansAntrumAgedAged 80 and overbusiness.industryStomachReproducibility of ResultsGeneral MedicineMiddle Agedmedicine.diseaseEndocrinologymedicine.anatomical_structureGastric MucosaPredictive value of testsBiomarker (medicine)FemaleDietary ProteinsGastritismedicine.symptomAtrophybusinessAdvances in medical sciences
researchProduct

Novel Probiotic Bifidobacterium bifidum CECT 7366 Strain Active against the Pathogenic Bacterium Helicobacter pylori▿

2010

ABSTRACT Helicobacter pylori is considered one of the major risk factors underlying the development of gastritis and gastric and duodenal ulcers. Moreover, 50% of the population carries this bacterium, and consequently, when it is detected, eradication of H. pylori is strongly recommended. Regarding the use of probiotics as functional agents, several studies have shown that there is a direct relationship between the addition of certain probiotic bacteria and in vitro inhibition of H. pylori ; however, in vivo studies showing bifidobacterial activity against H. pylori remain scarce. In this study, a Bifidobacterium bifidum strain which proved active in vitro against H. pylori has been isolat…

Gastrointestinal DiseasesPopulationved/biology.organism_classification_rank.speciesMolecular Sequence DataPublic Health MicrobiologyApplied Microbiology and BiotechnologyPolymerase Chain Reactionlaw.inventionMicrobiologyHelicobacter InfectionsProbioticMiceIntestinal mucosaIn vivolawRNA Ribosomal 16SAntibiosisAnimalsIntestinal MucosaeducationPathogenBifidobacteriumeducation.field_of_studyBifidobacterium bifidumEcologybiologyBase SequenceHelicobacter pylorived/biologySequence Analysis RNAProbioticsSequence Analysis DNAHelicobacter pyloribiology.organism_classificationBifidobacteriumFood ScienceBiotechnology
researchProduct

Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals

2011

Claudin-18 isoform 2 (CLDN18.2) is one of the few members of the human claudin family of tight junction molecules with strict restriction to one cell lineage. The objective of the current study was to compare molecular structure and tissue distribution of this gastrocyte specific molecule in mammals. We show here that the CLDN18.2 protein sequence is highly conserved, in particular with regard to functionally relevant domains in mouse, rat, rabbit, dog, monkey and human and also in lizards. Moreover, promoter regions of orthologs are highly homologous, including the binding site of the transcription factor cyclic AMP-responsive element binding protein (CREB), which is known to regulate acti…

Gene isoformmiceMolecular Sequence DataGene Expressionmolecular structureMammals/geneticsBiologyphylogenyRATSConserved sequenceEvolution MolecularDogsProtein Isoforms/geneticsSequence Homology Nucleic AcidGene expressionGeneticsProtein IsoformsAnimalsTissue DistributionAmino Acid SequenceMembrane Proteins/geneticsBinding sitePromoter Regions GeneticClaudinGeneTranscription factorConserved SequenceGastric Mucosa/metabolismMammalsRegulation of gene expressionGeneticsBinding SitesBase SequenceStomachStomach/cytologyMembrane ProteinsCREB-Binding Protein/metabolismHaplorhiniGeneral MedicineCREB-Binding ProteinGene Expression RegulationGastric MucosaOrgan SpecificityMultigene FamilyClaudinsRabbitsGene
researchProduct